Theravance Biopharma, Inc. Severance Costs
Theravance Biopharma, Inc. (TBPH) reported Severance Costs of $1.77 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2021-11-08
- Theravance Biopharma, Inc. severance costs for the quarter ending 2021-09-30 was $1.77M.
- Theravance Biopharma, Inc. severance costs for the quarter ending 2019-12-31 was $0.00.
- Theravance Biopharma, Inc. severance costs for the quarter ending 2019-09-30 was -$100.00K.
- Theravance Biopharma, Inc. severance costs for the quarter ending 2019-06-30 was -$300.00K.
- Theravance Biopharma, Inc. severance costs for fiscal 2019 was $3.50M.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2021-09-30 | $1.77M 10-Q · filed 2021-11-08 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$100.00K derived: sum of 2 quarters · filed 2021-02-26 | -$400.00K derived: sum of 3 quarters · filed 2021-02-26 | $3.50M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$400.00K derived: sum of 2 quarters · filed 2019-11-08 | $3.50M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $3.60M 10-Q · filed 2019-08-05 | ||
| 2019-03-31 | $3.90M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |